Xingxing D. Chen
No.270 Dong'an Road
Shanghai, 200032, China
Shanghai, 200032, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 53 publications
A Prospective Phase 2 Trial of Hypofractionated Stereotactic Radiation Therapy for Patients With 1 to 10 Brain Metastases From Breast Cancer.
Journal: International journal of radiation oncology, biology, physics
Published: August 17, 2025
Association of Multi-Kingdom Skin Microbiota With Radiation Dermatitis in Patients With Breast Cancer After Reconstructive Surgery: A Prospective, Longitudinal Study.
Journal: International journal of radiation oncology, biology, physics
Published: January 02, 2025
Dual Inhibition of CDK4/6 and CDK7 Suppresses Triple-Negative Breast Cancer Progression via Epigenetic Modulation of SREBP1-Regulated Cholesterol Metabolism.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: October 17, 2024
Hypofractionated partial breast irradiation after breast-conserving surgery for patients with early stage breast cancer in China Mainland: a single-arm prospective trial.
Journal: Scientific reports
Published: October 04, 2024
Post-mastectomy hypofractionated versus conventionally fractionated radiation therapy for patients receiving immediate breast reconstruction: Subgroup analysis of a phase III randomized trial.
Journal: Clinical and translational radiation oncology
Published: August 08, 2024
Clinical outcomes after post-operative radiotherapy for breast cancer patients presenting with ipsilateral supraclavicular metastasis: considerations on the cranial border of irradiation field.
Journal: Breast cancer (Tokyo, Japan)
Published: August 07, 2024
Integrating radiosensitivity index and triple-negative breast cancer subtypes reveals SERPINB5 as a radioresistance biomarker in triple-negative breast cancer.
Journal: Clinical and translational medicine
Published: March 13, 2024
CXCR6 expression correlates with radiotherapy response and immune context in triple-negative breast cancer-experimental studies.
Journal: International journal of surgery (London, England)
Published: January 21, 2024
Brain Radiotherapy With Pyrotinib and Capecitabine in Patients With ERBB2-Positive Advanced Breast Cancer and Brain Metastases: A Nonrandomized Phase 2 Trial.
Journal: JAMA oncology
Published: January 04, 2024
Adjuvant medial versus entire supraclavicular lymph node irradiation in high-risk early breast cancer (SUCLANODE): a protocol for a multicenter, randomized, open-label, phase 3 trial.
Journal: BMC cancer
Published: September 16, 2023
Last Updated: 09/26/2026